BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17620042)

  • 1. Molecular diagnostics and proteomics on the outskirts of personalized medicine.
    Goldknopf IL
    Expert Rev Mol Diagn; 2007 Jul; 7(4):339-43. PubMed ID: 17620042
    [No Abstract]   [Full Text] [Related]  

  • 2. What is wrong with clinical proteomics?
    Di Meo A; Diamandis EP; Rodriguez H; Hoofnagle AN; Ioannidis J; Lopez M
    Clin Chem; 2014 Oct; 60(10):1258-66. PubMed ID: 24831563
    [No Abstract]   [Full Text] [Related]  

  • 3. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of multiple proteomic platforms in a pipeline for new diagnostics.
    Anderson NL
    Mol Cell Proteomics; 2005 Oct; 4(10):1441-4. PubMed ID: 16020426
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for proteomics in kidney stone disease.
    Vinaiphat A; Thongboonkerd V
    Expert Rev Proteomics; 2017 Mar; 14(3):185-187. PubMed ID: 28092479
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular diagnostics: hurdles for clinical implementation.
    Fortina P; Surrey S; Kricka LJ
    Trends Mol Med; 2002 Jun; 8(6):264-6. PubMed ID: 12067610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tales of the genome. Perseverare diabolicum?].
    Jordan B
    Med Sci (Paris); 2012; 28(6-7):659-62. PubMed ID: 22805144
    [No Abstract]   [Full Text] [Related]  

  • 9. A focus on recent advances in proteomics - one step closer to entrance into the clinical arena.
    Rai AJ; Merlini G
    Clin Chem Lab Med; 2009; 47(6):625-6. PubMed ID: 19527135
    [No Abstract]   [Full Text] [Related]  

  • 10. Should genetic testing go digital?
    VanInsberghe M; Heyries KA; Hansen CL
    Expert Rev Mol Diagn; 2012 Mar; 12(2):111-4. PubMed ID: 22369369
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic method patents and harms to follow-on innovation.
    Harv Law Rev; 2013 Mar; 126(5):1370-91. PubMed ID: 25330558
    [No Abstract]   [Full Text] [Related]  

  • 12. [Precision Oncology: Approaching the Target].
    Hiddemann W
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteomics technologies for biomarker discovery in multiple sclerosis.
    Singh V; Hintzen RQ; Luider TM; Stoop MP
    J Neuroimmunol; 2012 Jul; 248(1-2):40-7. PubMed ID: 22129845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic vitrectomy in uveitis: possibilities of molecular biology].
    Becker MD; Bodaghi B; Holz FG; Harsch N; Hoang PL
    Ophthalmologe; 2003 Oct; 100(10):796-801. PubMed ID: 14618351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tasks and expectations for drug design based on pharmacogenomics].
    Uyama Y
    Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):432-5. PubMed ID: 16463462
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Towards a national standardisation of NGS studies in the diagnosis of myopathies].
    Krahn M; Cerino M; Campana-Salort E; Cossée M
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():30-33. PubMed ID: 29139383
    [No Abstract]   [Full Text] [Related]  

  • 18. New developments in proteomics.
    Massing MW; Misiurek J; Chadaram SR; Marx CE; Madison R
    N C Med J; 2007; 68(2):119-22. PubMed ID: 17566558
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic Biomarkers: Are We Moving from Discovery to Clinical Application?
    Parker LA; Chilet-Rosell E; Hernández-Aguado I; Pastor-Valero M; Gea S; Lumbreras B
    Clin Chem; 2018 Nov; 64(11):1657-1667. PubMed ID: 30213783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Bode-Lesniewska B
    Ther Umsch; 2017 Sep; 74(4):204-208. PubMed ID: 28950776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.